Evidence map›Paper›PMID 41918988›Full record

ArticleGut microbes reports2026

Viable gut bacterial metrics associated with intestinal eubiosis and dysbiosis.

Tomoaki Naito, Hiromi Setoyama, Noriko Kato-Nagaoka, Tatsuichiro Shima, Tadashi Sato, Kaoru Moriyama-Ohara, Sohei Arase, Takashi Kurakawa, Misato Horino-Higuchi, Saya Tajima and 12 more

Abstract read
In one paragraph

Article in Gut microbes reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Tomoaki NaitoYakult Central Institute, Tokyo, Japan.ORCID https://orcid.org/0009-0001-2963-4029
Hiromi SetoyamaYakult Central Institute, Tokyo, Japan.
Noriko Kato-NagaokaYakult Central Institute, Tokyo, Japan.
Tatsuichiro ShimaYakult Central Institute, Tokyo, Japan.
Tadashi SatoYakult Central Institute, Tokyo, Japan.
Kaoru Moriyama-OharaYakult Central Institute, Tokyo, Japan.
Sohei AraseYakult Central Institute, Tokyo, Japan.
Takashi KurakawaYakult Central Institute, Tokyo, Japan.
Misato Horino-HiguchiYakult Central Institute, Tokyo, Japan.
Saya TajimaYakult Central Institute, Tokyo, Japan.
Tomomi Suzuki-OhnariYakult Central Institute, Tokyo, Japan.
Yoshimi Aiyama-SuzukiYakult Central Institute, Tokyo, Japan.
Taeko HaraYakult Central Institute, Tokyo, Japan.
Eiichiro NaitoYakult Central Institute, Tokyo, Japan.
Nami HayashiBenesse Institute for Research on KAIGO (Continuing Care), Benesse Style Care Co., Ltd., Tokyo, Japan.
Kozo TsurutaDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Tetsuji HoriYakult Central Institute, Tokyo, Japan.ORCID https://orcid.org/0000-0002-1118-1949
Akito Kataoka-KatoYakult Central Institute, Tokyo, Japan.
Ryoko FukudaBenesse Institute for Research on KAIGO (Continuing Care), Benesse Style Care Co., Ltd., Tokyo, Japan.
Keiichi MitsuyamaDepartment of Gastroenterology, Inflammatory Bowel Disease Center, St. Mary's Hospital, Fukuoka, Japan.
Satoshi MatsumotoYakult Central Institute, Tokyo, Japan.
Hirokazu TsujiYakult Central Institute, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2856-6447

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbial turnover in humans remains poorly understood. We evaluated gut bacterial viability by quantifying viable cells and relating them to indicators of gut environmental status. Fecal microbial loads (microbial cells per gram feces) were quantified by flow cytometry using the DNA-intercalating dye SytoBC, and viable bacteria were identified by fluorescence in situ hybridization with the 16S rRNA-targeted Eub338 probe. Bacteria retaining sufficient rRNA were defined as viable, and the living bacterial rate was calculated as the proportion of Eub338-positive cells among SytoBC-positive cells. These metrics were applied to starvation‑cultured gut bacterial strains and fecal samples from patients with ulcerative colitis (UC), older adults, and healthy individuals. Starvation culture showed time‑dependent decreases in living bacterial rate and viable cell counts, consistent with colony-forming unit measurements. Patients with active UC exhibited reduced fecal microbial loads and viable microbial loads. Living bacterial rates negatively correlated with fecal calprotectin and Mayo score. In older adults, reduced living bacterial rates and viable

Indexed as

bacterial viabilityBifidobacteriaceaecalprotectinLachnospiraceaeViable gut microbiota

Identifiers

PMID41918988
PMCPMC13034633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.